European Organisation for Research and Treatment of Cancer - EORTC

NCT06326190

Phase 2Recruiting136 people22 Mar 2024clinicaltrials.gov

NCT05512364

Phase 3Recruiting220 people23 Aug 2022clinicaltrials.gov

NCT05128773

CollaboratorPhase 3Terminated3 people22 Nov 2021clinicaltrials.gov

NCT04796454

Phase 2Withdrawn0 people12 Mar 2021clinicaltrials.gov

NCT04780464

Phase 3Terminated14 people3 Mar 2021clinicaltrials.gov

NCT04685616

CollaboratorPhase 3Recruiting1,042 people28 Dec 2020clinicaltrials.gov

NCT04402073

Phase 2Terminated20 people26 May 2020clinicaltrials.gov

NCT03673735

Phase 3Withdrawn0 people17 Sept 2018clinicaltrials.gov

NCT03620149

Phase 2Terminated2 people8 Aug 2018clinicaltrials.gov

NCT03609047

Phase 2Active, not recruiting366 people1 Aug 2018clinicaltrials.gov

NCT03517137

Phase 2Active, not recruiting150 people7 May 2018clinicaltrials.gov

NCT03488810

Phase 3Withdrawn0 people5 Apr 2018clinicaltrials.gov

NCT03224104

Phase 1Completed71 people21 Jul 2017clinicaltrials.gov

NCT03005015

Phase 2Withdrawn0 people29 Dec 2016clinicaltrials.gov

NCT02866370

CollaboratorPhase 2Status unknown120 people15 Aug 2016clinicaltrials.gov

NCT02659384

Phase 2Completed122 people20 Jan 2016clinicaltrials.gov

NCT02467582

CollaboratorPhase 3Terminated1,040 people10 Jun 2015clinicaltrials.gov

NCT02436733

Phase 2Status unknown64 people7 May 2015clinicaltrials.gov

NCT02375204

CollaboratorPhase 3Active, not recruiting420 people2 Mar 2015clinicaltrials.gov

NCT02129699

CollaboratorPhase 3Terminated595 people2 May 2014clinicaltrials.gov